BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25800333)

  • 1. From translational research to open technology innovation systems.
    Savory C; Fortune J
    J Health Organ Manag; 2015; 29(2):200-20. PubMed ID: 25800333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare technology co-operatives: Innovative about innovation.
    Heron NM; Tindale WB
    J Med Eng Technol; 2014; 39(7):378-81. PubMed ID: 26453035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge translation in healthcare: Incorporating theories of learning and knowledge from the management literature.
    Oborn E; Barrett M; Racko G
    J Health Organ Manag; 2013; 27(4):412-31. PubMed ID: 24003630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology transfer from biomedical research to clinical practice: measuring innovation performance.
    Balas EA; Elkin PL
    Eval Health Prof; 2013 Dec; 36(4):505-17. PubMed ID: 24142938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A theoretical framework to support research of health service innovation.
    Fox A; Gardner G; Osborne S
    Aust Health Rev; 2015 Feb; 39(1):70-75. PubMed ID: 25513878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trialability, observability and risk reduction accelerating individual innovation adoption decisions.
    Hayes KJ; Eljiz K; Dadich A; Fitzgerald JA; Sloan T
    J Health Organ Manag; 2015; 29(2):271-94. PubMed ID: 25800337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of adoption: measuring evidence uptake by individuals and organizations.
    Donaldson NE; Rutledge DN; Ashley J
    Worldviews Evid Based Nurs; 2004; 1 Suppl 1():S41-51. PubMed ID: 17129334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding and investing in healthcare innovation and collaboration.
    Day-Duro E; Lubitsh G; Smith G
    J Health Organ Manag; 2020 Apr; ahead-of-print(ahead-of-print):. PubMed ID: 32250574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crossing and creating boundaries in healthcare innovation.
    Ingerslev K
    J Health Organ Manag; 2016 Jun; 30(4):541-57. PubMed ID: 27296877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New indicators and indexes for benchmarking university-industry-government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project.
    Edmunds LD; Gluderer S; Ovseiko PV; Kamerling R; Ton J; Vis L; Jenni M; Tutton G; Lawton-Smith H; Nadabán MV; Rab M; Rees J; Anson J; Rushforth AD; Allen M; Buchan AM; Vendrell M; Casta A; Mehes G; Hogendoorn PCW; Hafen E; Hassan AB
    Health Res Policy Syst; 2019 Jan; 17(1):10. PubMed ID: 30691504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing some major determinants for hospital innovation success.
    Caccia-Bava Mdo C; Guimaraes VC; Guimaraes T
    Int J Health Care Qual Assur; 2009; 22(5):454-70. PubMed ID: 19725367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding healthcare innovation systems: the Stockholm region case.
    Larisch LM; Amer-Wåhlin I; Hidefjäll P
    J Health Organ Manag; 2016 Nov; 30(8):1221-1241. PubMed ID: 27834601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unmet needs: relevance to medical technology innovation?
    McCarthy AD; Sproson L; Wells O; Tindale W
    J Med Eng Technol; 2014; 39(7):382-7. PubMed ID: 26415684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and deployment of electronic personal health records records: a strategic positioning perspective.
    Lewis M; Baxter R; Pouder R
    J Health Organ Manag; 2013; 27(5):577-600. PubMed ID: 24341178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizing the strategic opportunities of emerging technologies by building up innovation system: monoclonal antibody development in China.
    Zhang MY; Li J; Hu H; Wang YT
    Health Res Policy Syst; 2015 Nov; 13():64. PubMed ID: 26537659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Health care innovation from a territorial perspective: a call for a new approach].
    Costa LS; Gadelha CA; Maldonado J
    Rev Saude Publica; 2012 Dec; 46 Suppl 1():59-67. PubMed ID: 23250395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technology-based innovation for independent living: policy and innovation in the United Kingdom, Scandinavia, and the United States.
    Berridge C; Furseth PI; Cuthbertson R; Demello S
    J Aging Soc Policy; 2014; 26(3):213-28. PubMed ID: 24716894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technology diffusion and substitution of medical innovations.
    Serra-Sastre V; McGuire A
    Adv Health Econ Health Serv Res; 2012; 23():149-75. PubMed ID: 23156664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introducing innovation in a management development programme for a UK primary care organisation.
    Smith P; Hampson L; Scott J; Bower K
    J Health Organ Manag; 2011; 25(3):261-80. PubMed ID: 21845982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.